Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Optical Genome Mapping Market Outlook from 2024 to 2034

According to the recent research led by Future Market Insights, the global optical genome mapping market will attain a valuation of US$ 167.0 million by the year 2024. Projections indicate a subsequent increase to US$ 1.3 billion by 2034, demonstrating a significant growth trajectory. The expansion represents a CAGR of 23.5% during the forecast period.

Attributes Key Insights
Optical Genome Mapping Market Estimated Size in 2024 US$ 167.0 million
Projected Market Value in 2034 US$ 1.3 billion
Value-based CAGR from 2024 to 2034 23.5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Motivators Enhancing Market Growth

  • Advancements in genomic research have led to the development of technologies that enable accurate and efficient mapping of genomes.
  • Increasing demand for personalized medicine facilitates the identification of genetic variations associated with diseases.
  • Cost effectiveness and efficiency lead to rapid analysis of large genomes with high accuracy, making them attractive for research and clinical applications.
  • Expansion of applications is driven by the need for accurate and comprehensive genomic analysis in clinical diagnostics, cancer research, and agriculture.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The optical genome mapping market expanded at a whopping 28.0% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 23.5% over the forecast period 2024 to 2034.

The market saw a steady growth during the historical period, owing to advances in optical genome mapping technologies. Adoption of optical genome mapping in clinical settings expanded, driven by the need for comprehensive genomic analysis for disease diagnosis, treatment selection, and monitoring.

Increasing investments in genomic research and the rise of precision medicine had accelerated the demand for advanced genomic analysis tools, including optical genome mapping platforms.

Regulatory approvals and guidelines for optical genome mapping technologies facilitated market penetration and adoption in healthcare systems. Adoption of optical genome mapping in agriculture will increase, enabling precision breeding, crop improvement, and genetic resource conservation.

Integration with machine learning, big data analytics and AI will enhance data analysis capabilities, enabling deeper insights into genomic data and accelerating research and discovery. Efforts to expand market presence in emerging economies and regions with growing healthcare infrastructure will drive global market penetration and revenue growth.

Growing investments in genomics research, biotechnology, and healthcare infrastructure will fuel innovation, product development, and market expansion in the optical genome mapping sector.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Major Contributors of Optical Genome Mapping Market

  • Technological innovations are enhancing the capabilities of optical genome mapping platforms, improving their accuracy, throughput, and scalability.
  • Increasing Investment and Funding are fuelling the development and commercialization of optical genome mapping technologies.
  • Collaborations between academic institutions, research organizations, and biotechnology companies facilitate the sharing of resources.
  • Regulatory support and guidelines are enabling broader adoption and integration into healthcare systems.

Factors Hampering Optical Genome Mapping Market

  • High initial costs may deter adoption, especially among smaller research institutions, laboratories, and healthcare facilities with limited financial resources.
  • Lack of skilled personnel and computational resources for data analysis may pose a barrier to adoption.
  • Limited throughput and scalability may restrict the applicability of optical genome mapping in high throughput research and clinical settings.
  • Challenges in sample preparation may affect data accuracy and reproducibility, impacting the reliability and adoption of optical genome mapping technologies.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent Industries

Future Market Insights has compared two other industries, gene editing tools market, and personal genome testing market. Rise of precision agriculture can identify desirable traits and accelerate breeding processes, leading to the development of high yield, resilient crops.

Advancements in gene editing technologies have revolutionized the field of molecular biology, enabling researchers to edit genes with accuracy. Increasing demand for personalized medicine allows for healthcare interventions, disease risk assessment, and treatment optimization.

Optical Genome Mapping Market:

Attributes Optical Genome Mapping Market
CAGR from 2024 to 2034 23.5%
Key Trends
  • Integration with ML and AI facilitates the discovery of novel genetic insights and biomarkers.
  • Emergence of microbiome research offers insights into the composition and function of microbiomes in various environments.
Opportunity
  • Growing demand for prenatal testing offers a non-invasive method for detecting structural variations and chromosomal abnormalities in fetal genomes.
  • Optical genome mapping technologies are increasingly applied in non-human genomics research for biodiversity conservation.

Gene Editing Tools Market:

Attributes Gene Editing Tools Market
CAGR from 2022 to 2029 18.8%
Key Trends
  • Rise of gene therapy and genome engineering has augmented the demand for gene editing tools.
  • Expanding applications in biomedical research fuels the demand for these tools in research laboratories and academic institutions.
Opportunity
  • Expansion of CRISPR based applications are opening up new avenues for the market growth.
  • Growing investment and funding accelerates technology innovation, product development, and commercialization of gene editing tools.

Personal Genome Testing Market:

Attributes Personal Genome Testing Market
CAGR from 2022 to 2032 10.1%
Key Trends
  • Increasing awareness of genetic health risks is driving demand for personal genome testing.
  • Innovations in genomic technologies have made personal genome testing more accessible and affordable.
Opportunity
  • Integration with digital health platforms enables personalized health monitoring and management.
  • Expansion of direct to consumer testing allows individuals to order genetic tests online or through retail channels without involving healthcare providers.

Country-wise Insights

Advancements in Genome Research Will Create Opportunities in the United States

Country The United States
CAGR through 2034 23.8%

The optical genome mapping market in the United States will expand at a CAGR of 23.8% through 2034. The country is home to leading academic institutions, research organizations, and biotechnology companies at the forefront of genomic research.

Ongoing advancements in genomic technologies, including optical genome mapping, drive research innovation and stimulate market growth.

The United States is at the forefront of adopting precision medicine approaches, which rely on comprehensive genomic analysis to tailor medical treatments. Optical genome mapping technologies play a crucial role in this paradigm shift by providing high resolution analysis of genomes.

Strong Academic and Research Institutions to Enhance the Market Growth in the United Kingdom

Country The United Kingdom
CAGR through 2034 24.7%

The optical genome mapping market in the United Kingdom to expand at a CAGR of 24.7% through 2034. The country is home to renowned academic and research institutions with expertise in genomics and molecular biology.

Collaboration between academia, industry, and healthcare providers fosters innovation, technology development, and translation of research findings.

The United Kingdom has made significant investments in genomic medicine initiatives, such as the 100,000 Genomes Project and the Genomics England program. Government support for genomic research and healthcare infrastructure drives the adoption of advanced genomic technologies like optical genome mapping.

Biotechnology Innovation Will Augment the Market Prospects in China

Country China
CAGR through 2034 24.4%

Optical genome mapping trends in China are taking a turn for the better. A 24.4% CAGR is forecast for the country from 2024 to 2034. The country has a rapidly growing biotechnology ecosystem with a strong focus on innovation and entrepreneurship.

Biotechnology start-ups and companies in China leverage government support, and access to capital to commercialize advanced genomic technologies.

China is investing in modernizing its healthcare infrastructure and implementing precision medicine initiatives. Integration of genomic technologies, including optical genome mapping, into clinical practice and healthcare delivery systems to fuel the market growth.

Research Funding and Support to Stimulate the Market Growth in Japan

Country Japan
CAGR through 2034 25.4%

The optical genome mapping market in Japan is poised to expand at a CAGR of 25.4% through 2034. The country provides research funding and support for genomic research and technology development.

Research grants, funding initiatives, and academic industry collaborations stimulate innovation, drive technology adoption. Japan actively collaborates with international partners in genomic research, healthcare, and industry.

Collaborative initiatives and partnerships enable knowledge exchange, technology transfer, and market expansion, driving growth opportunities.

Focus on Cancer Genomics to Accelerate the Market Aspects in Korea

Country Korea
CAGR through 2034 26.0%

The optical genome mapping market in Korea will expand at a CAGR of 26.0% through 2034. The country has a high incidence of cancer and is actively engaged in cancer genomics research and precision oncology initiatives.

Optical genome mapping technologies enable comprehensive profiling of tumor genomes, identification of driver mutations, and characterization of tumor heterogeneity.

Korea has been an early adopter of next generation sequencing technologies for genomic research and clinical applications. Optical genome mapping complements NGS by providing high resolution structural variation analysis.

Category-wise Insights

The below table highlights how instruments segment is leading the market in terms of component, and will account for a CAGR of 23.2% through 2034. Based on application, the research segment is gaining heights and will to account for a CAGR of 23.0% through 2034.

Category CAGR through 2034
Instruments 23.2%
Research 23.0%

Instruments Segment Witnesses High Demand for Optical Genome Mapping

Based on component, the instruments segment will dominate the optical genome mapping market. Increasing investments in genomic research and biotechnology drive the demand for instruments used in optical genome mapping.

Research institutions, academic laboratories, and biotechnology companies invest in advanced instruments to support their genomic research initiatives. The integration of optical genome mapping into clinical diagnostics drives demand for instruments suitable for use in healthcare settings.

Instruments capable of processing clinical samples, providing accurate and reliable results, and meeting regulatory requirements for diagnostic use are in high demand.

Research Segment to Hold High Demand for Optical Genome Mapping

In terms of application, the research segment will dominate the optical genome mapping market. Optical genome mapping is particularly valuable for the analysis of complex genomes, including large and repetitive regions that are challenging to analyze using other genomic technologies.

Researchers studying complex organisms, such as plants, animals, and microorganisms, rely on optical genome mapping to unravel the complexities of their genomes. Optical genome mapping offers high resolution analysis of structural variations in genomes, such as insertions, deletions, duplications, and translocations.

There is a growing demand for optical genome mapping in structural variation analysis, with increasing recognition of the importance of structural variations in disease pathogenesis and population genetics.

Competitive Landscape

The competitive landscape of the optical genome mapping market is dynamic and evolving, characterized by the presence of established players, emerging companies, and technological advancements driving innovation and market growth.

Company Portfolio

  • Bionano Genomics, Inc. is a leading provider of optical genome mapping solutions for genomic analysis. The flagship product of the company, the Saphyr system, offers high throughput optical genome mapping for structural variation analysis.
  • Nucleome Informatics Private Limited is a biotechnology company specializing in computational genomics and genomic data analysis. They offer advanced bioinformatics tools and software solutions for analyzing optical genome mapping data.

Key Coverage in the Optical Genome Mapping Industry Report

  • Optical Genome Mapping technology
  • Genomic analysis solutions
  • Structural variation detection
  • High-resolution DNA mapping
  • Next-generation genome sequencing
  • Optical Genome Mapping Market
  • Next-Generation Sequencing Market
  • Molecular Diagnostics Market

Report Scope

Attribute Details
Estimated Market Size in 2024 US$ 167.0 million
Projected Market Valuation in 2034 US$ 1.3 billion
Value-based CAGR 2024 to 2034 23.5%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ Million
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Market Segments Covered
  • Component
  • Application
  • Solution
  • End Use
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Bionano Genomics Inc.
  • Nucleome Informatics Private Limited
  • Nabsys Inc.
  • Praxis Genomics LLC
  • PerkinElmer Inc.
  • OpGen Inc.
  • SourceBio International Limited
  • MedGenome Labs Private Limited
  • Genohub Inc.
  • Cerba HealthCare

Segmentation Analysis of the Optical Genome Mapping Market

By Component:

  • Instruments
  • Consumables and Reagents
  • Services and Software

By Application:

  • Research
  • Diagnostics

By Solution:

  • Structural Variant Detection
  • Genome Assembly
  • Microbial Strain Typing
  • Other Solutions

By End Use:

  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes
  • Diagnostic Laboratories
  • Other End Users

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What is the anticipated value of the Optical Genome Mapping market in 2024?

The optical genome mapping market is projected to reach a valuation of US$ 167.0 million in 2024.

What is the expected CAGR for the Optical Genome Mapping market until 2034?

The optical genome mapping industry is set to expand by a CAGR of 23.5% through 2034.

How much valuation is projected for the Optical Genome Mapping market in 2034?

The optical genome mapping market is forecast to reach US$ 1.3 billion by 2034.

Which country is projected to lead the Optical Genome Mapping market?

Korea is set to be the top performing market, exhibiting a CAGR of 26.0% through 2034.

Which is the dominant component in the Optical Genome Mapping domain?

Instruments segment is preferred, and will account for a CAGR of 23.2% through 2034.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034

        5.3.1. Instruments

        5.3.2. Consumables & Reagents

        5.3.3. Services & Software

    5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        6.3.1. Research

        6.3.2. Diagnostics

    6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Solution

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Solution, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Solution, 2024 to 2034

        7.3.1. Structural Variant Detection

        7.3.2. Genome Assembly

        7.3.3. Microbial Strain Typing

        7.3.4. Other Solutions

    7.4. Y-o-Y Growth Trend Analysis By Solution, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Solution, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2019 to 2023

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2024 to 2034

        8.3.1. Pharmaceutical & Biotechnology Companies

        8.3.2. Research & Academic Institutes

        8.3.3. Diagnostic Laboratories

        8.3.4. Other End-Users

    8.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023

    8.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. South Asia and Pacific

        9.3.6. East Asia

        9.3.7. Middle East and Africa

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Component

        10.2.3. By Application

        10.2.4. By Solution

        10.2.5. By End-use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Component

        10.3.3. By Application

        10.3.4. By Solution

        10.3.5. By End-use

    10.4. Key Takeaways

11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Component

        11.2.3. By Application

        11.2.4. By Solution

        11.2.5. By End-use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Component

        11.3.3. By Application

        11.3.4. By Solution

        11.3.5. By End-use

    11.4. Key Takeaways

12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Western Europe

        12.2.2. By Component

        12.2.3. By Application

        12.2.4. By Solution

        12.2.5. By End-use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Component

        12.3.3. By Application

        12.3.4. By Solution

        12.3.5. By End-use

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. Poland

            13.2.1.2. Russia

            13.2.1.3. Czech Republic

            13.2.1.4. Romania

            13.2.1.5. Rest of Eastern Europe

        13.2.2. By Component

        13.2.3. By Application

        13.2.4. By Solution

        13.2.5. By End-use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Component

        13.3.3. By Application

        13.3.4. By Solution

        13.3.5. By End-use

    13.4. Key Takeaways

14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. India

            14.2.1.2. Bangladesh

            14.2.1.3. Australia

            14.2.1.4. New Zealand

            14.2.1.5. Rest of South Asia and Pacific

        14.2.2. By Component

        14.2.3. By Application

        14.2.4. By Solution

        14.2.5. By End-use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Component

        14.3.3. By Application

        14.3.4. By Solution

        14.3.5. By End-use

    14.4. Key Takeaways

15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. China

            15.2.1.2. Japan

            15.2.1.3. South Korea

        15.2.2. By Component

        15.2.3. By Application

        15.2.4. By Solution

        15.2.5. By End-use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Component

        15.3.3. By Application

        15.3.4. By Solution

        15.3.5. By End-use

    15.4. Key Takeaways

16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Component

        16.2.3. By Application

        16.2.4. By Solution

        16.2.5. By End-use

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Component

        16.3.3. By Application

        16.3.4. By Solution

        16.3.5. By End-use

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Market Share Analysis, 2023

            17.1.1.1. By Component

            17.1.1.2. By Application

            17.1.1.3. By Solution

            17.1.1.4. By End-use

    17.2. Canada

        17.2.1. Market Share Analysis, 2023

            17.2.1.1. By Component

            17.2.1.2. By Application

            17.2.1.3. By Solution

            17.2.1.4. By End-use

    17.3. Brazil

        17.3.1. Market Share Analysis, 2023

            17.3.1.1. By Component

            17.3.1.2. By Application

            17.3.1.3. By Solution

            17.3.1.4. By End-use

    17.4. Mexico

        17.4.1. Market Share Analysis, 2023

            17.4.1.1. By Component

            17.4.1.2. By Application

            17.4.1.3. By Solution

            17.4.1.4. By End-use

    17.5. Germany

        17.5.1. Market Share Analysis, 2023

            17.5.1.1. By Component

            17.5.1.2. By Application

            17.5.1.3. By Solution

            17.5.1.4. By End-use

    17.6. UK

        17.6.1. Market Share Analysis, 2023

            17.6.1.1. By Component

            17.6.1.2. By Application

            17.6.1.3. By Solution

            17.6.1.4. By End-use

    17.7. France

        17.7.1. Market Share Analysis, 2023

            17.7.1.1. By Component

            17.7.1.2. By Application

            17.7.1.3. By Solution

            17.7.1.4. By End-use

    17.8. Spain

        17.8.1. Market Share Analysis, 2023

            17.8.1.1. By Component

            17.8.1.2. By Application

            17.8.1.3. By Solution

            17.8.1.4. By End-use

    17.9. Italy

        17.9.1. Market Share Analysis, 2023

            17.9.1.1. By Component

            17.9.1.2. By Application

            17.9.1.3. By Solution

            17.9.1.4. By End-use

    17.10. Poland

        17.10.1. Market Share Analysis, 2023

            17.10.1.1. By Component

            17.10.1.2. By Application

            17.10.1.3. By Solution

            17.10.1.4. By End-use

    17.11. Russia

        17.11.1. Market Share Analysis, 2023

            17.11.1.1. By Component

            17.11.1.2. By Application

            17.11.1.3. By Solution

            17.11.1.4. By End-use

    17.12. Czech Republic

        17.12.1. Market Share Analysis, 2023

            17.12.1.1. By Component

            17.12.1.2. By Application

            17.12.1.3. By Solution

            17.12.1.4. By End-use

    17.13. Romania

        17.13.1. Market Share Analysis, 2023

            17.13.1.1. By Component

            17.13.1.2. By Application

            17.13.1.3. By Solution

            17.13.1.4. By End-use

    17.14. India

        17.14.1. Market Share Analysis, 2023

            17.14.1.1. By Component

            17.14.1.2. By Application

            17.14.1.3. By Solution

            17.14.1.4. By End-use

    17.15. Bangladesh

        17.15.1. Market Share Analysis, 2023

            17.15.1.1. By Component

            17.15.1.2. By Application

            17.15.1.3. By Solution

            17.15.1.4. By End-use

    17.16. Australia

        17.16.1. Market Share Analysis, 2023

            17.16.1.1. By Component

            17.16.1.2. By Application

            17.16.1.3. By Solution

            17.16.1.4. By End-use

    17.17. New Zealand

        17.17.1. Market Share Analysis, 2023

            17.17.1.1. By Component

            17.17.1.2. By Application

            17.17.1.3. By Solution

            17.17.1.4. By End-use

    17.18. China

        17.18.1. Market Share Analysis, 2023

            17.18.1.1. By Component

            17.18.1.2. By Application

            17.18.1.3. By Solution

            17.18.1.4. By End-use

    17.19. Japan

        17.19.1. Market Share Analysis, 2023

            17.19.1.1. By Component

            17.19.1.2. By Application

            17.19.1.3. By Solution

            17.19.1.4. By End-use

    17.20. South Korea

        17.20.1. Pricing Analysis

            17.20.1.1. By Component

            17.20.1.2. By Application

            17.20.1.3. By Solution

            17.20.1.4. By End-use

    17.21. GCC Countries

        17.21.1. Pricing Analysis

            17.21.1.1. By Component

            17.21.1.2. By Application

            17.21.1.3. By Solution

            17.21.1.4. By End-use

    17.22. South Africa

        17.22.1. Market Share Analysis, 2023

            17.22.1.1. By Component

            17.22.1.2. By Application

            17.22.1.3. By Solution

            17.22.1.4. By End-use

    17.23. Israel

        17.23.1. Market Share Analysis, 2023

            17.23.1.1. By Component

            17.23.1.2. By Application

            17.23.1.3. By Solution

            17.23.1.4. By End-use

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Component

        18.3.3. By Application

        18.3.4. By Solution

        18.3.5. By End-use

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Bionano Genomics, Inc.

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Nucleome Informatics Private Limited

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Nabsys, Inc.

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Praxis Genomics LLC

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. PerkinElmer, Inc.

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. OpGen, Inc.

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. SourceBio International Limited

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. MedGenome Labs Private Limited

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Genohub Inc.

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Cerba HealthCare

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Gene Editing Tool Market

Published : May 2024

Healthcare

Whole Genome Amplification Market

Published : May 2024

Healthcare

Genome Editing Market

Published : February 2024

Healthcare

Personal Genome Testing Market

Published : July 2022

Explore Healthcare Insights

View Reports

Optical Genome Mapping Market